MedTrace Logo

Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits

NCT06804044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-01-31

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if dietary interventions works to improve anthropometric measures in women with PCOS. The main questions it aims to answer are:

* Does intermittent fasting (IF) cause loss of body weight, fat and muscle mass?
* Can IF be considered more effective to medical and standart nutrition therapy (SDT)?
* What dietary problems do participants have when having IF diet?

Participants will:

* Follow IF, SDT, or no intervention for 8 weeks.
* Visit the clinic once every 2 weeks for check ups with a total of 5 visits for intervention groups IF and STD, visit at the beginning, second week and at the end for control group
* Keep dietary records

Conditions

  • Polycystic Ovary Syndrome
  • Weight Loss
  • Intermittent Fasting
  • Medical Nutrition Therapy
  • Caloric Restriction

Interventions

BEHAVIORAL

Intermittent Fasting

A 16:8 intermittent fasting with a daytime eating window model was applied.

BEHAVIORAL

Standart Diet Therapy

Meal plan with 3 main meals and 3 snacks was applied.

Sponsors & Collaborators

  • Bahçeşehir University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2023-05-30
Completion
2024-01-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06804044 on ClinicalTrials.gov